Exela Pharma Sciences
Corporate Round in 2021
Exela Pharma Sciences, LLC is a rapidly growing US-based specialty pharmaceutical company focused on the development, manufacturing, and marketing of proprietary and generic sterile injectable products. The company aims to improve patient outcomes while reducing overall healthcare costs by offering a range of products, including generic injectables, ophthalmic, and inhalation medications. With a commitment to alleviating drug shortages, Exela is recognized for its dedication to enhancing the supply chain and creating high-value employment opportunities in rural areas. By providing therapeutically effective formulations, Exela increases treatment options for healthcare providers and enhances the quality of life and treatment experience for patients.
Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services. Our solution interprets patient information in real-time and connects health systems and community-based organizations to support healthier outcomes, both inside and outside of hospital walls. Using cloud-based artificial intelligence with clinically-based natural language processing (NLP) and physician-supervised machine learning, our tools help streamline clinician workflows and improve patient outcomes. Combined, our solutions, Pieces Predict and Pieces Connect, create a comprehensive and unique solution for connected community health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.